Trade Mark 1868291 | IP Australia

Number: 1868291

IR number: 1361963

Words: SEED
Status: protected: Registered/protected
Priority date: 11 Jan 2017 (Convention)
Class: 5
Kind: Word

SEED

Goods & Services

Class 5:: Probiotic formulations, namely, lyophilized powders for medical purposes, in particular, for producing beneficial metabolites, modulating inflammation, increasing beneficial microbes, and inhibiting pathogens in the human microbiome; pharmaceutical preparations for microbiome dysbiosis resulting from the use of antibiotic medications and consumer health interventions for the restoration of balance to a perturbed human microbiome; probiotic formulations, namely, capsules for medical purposes, in particular, for producing beneficial metabolites, modulating inflammation, increasing beneficial microbes, and inhibiting pathogens in the human microbiome

Endorsements

By Virtue of Rule 22 of the Common Regulations of the Madrid Protocol, 1868291 was partially transformed from International Registration number 1361963 to National Registration 2209940 on 8 September 2021.

Convention details

Date:

11 Jan 2017

Number:

87297454

Country:

UNITED STATES OF AMERICA

Opposition details

No oppositions information available.

History and Publications

Date	Description
03 Nov 2021	IP Right Goods and Services Items updated	More
	Event description Class Number: 5 Previous details Class Number: 5 Class Items: Probiotic formulations made of bacteria, namely, capsules, suppositories, and lyophilized powders for medical purposes, in particular, for producing beneficial metabolites, modulating inflammation, increasing beneficial microbes, and inhibiting pathogens in the human microbiome; Probiotic formulations made of bacteria, namely, capsules, and lyophilized powders for medical purposes, in particular, for producing beneficial metabolites, modulating inflammation, increasing beneficial microbes, and inhibiting pathogens in the human microbiome; pharmaceutical preparations made of bacteria for microbiome dysbiosis resulting from the use of antibiotic medications and consumer health interventions for the restoration of balance to a perturbed human microbiome; probiotic and prebiotic formulations made of bacteria, namely, capsules, suppositories, and lyophilized powders for the developing infant gut microbiome, for supporting healthy vaginal microbiomes in pregnant women and supporting healthy breastfeeding, and for increasing strains of beneficial bacteria in infants New details Class Number: 5 Class Items: Probiotic formulations, namely, lyophilized powders for medical purposes, in particular, for producing beneficial metabolites, modulating inflammation, increasing beneficial microbes, and inhibiting pathogens in the human microbiome; pharmaceutical preparations for microbiome dysbiosis resulting from the use of antibiotic medications and consumer health interventions for the restoration of balance to a perturbed human microbiome; probiotic formulations, namely, capsules for medical purposes, in particular, for producing beneficial metabolites, modulating inflammation, increasing beneficial microbes, and inhibiting pathogens in the human microbiome
03 Nov 2021	IP right goods and service classes updated	More
	Event description Class Count: 1 Class Numbers:5 Previous details Class Count: 1 Class Numbers: 1; 5 New details Class Count: 1 Class Numbers: 5
10 Sep 2021	IP Right Goods and Services Items updated	More
	Event description Class Number: 5 Previous details Class Number: 5 Class Items: Probiotic formulations made of bacteria, namely, capsules, suppositories, and lyophilized powders for medical purposes, in particular, for producing beneficial metabolites, modulating inflammation, increasing beneficial microbes, and inhibiting pathogens in the human microbiome; probiotic and prebiotic formulations made of bacteria, namely, capsules, suppositories, and lyophilized powders for the developing infant gut microbiome, for supporting healthy vaginal microbiomes in pregnant women and supporting healthy breastfeeding, and for increasing strains of beneficial bacteria in infants; pharmaceutical preparations made of bacteria for microbiome dysbiosis resulting from the use of antibiotic medications and consumer health interventions for the restoration of balance to a perturbed human microbiome New details Class Number: 5 Class Items: Probiotic formulations made of bacteria, namely, capsules, and lyophilized powders for medical purposes, in particular, for producing beneficial metabolites, modulating inflammation, increasing beneficial microbes, and inhibiting pathogens in the human microbiome; pharmaceutical preparations made of bacteria for microbiome dysbiosis resulting from the use of antibiotic medications and consumer health interventions for the restoration of balance to a perturbed human microbiome
10 Sep 2021	IP right goods and service classes updated	More
	Event description Class Count: 1 Class Numbers:5 Previous details Class Count: 2 Class Numbers: 1; 5 New details Class Count: 1 Class Numbers: 5
09 Sep 2021	Transformation of Australian Trade Mark Requested
26 Nov 2020	Amendment to Amend Owner Requested
08 Feb 2019	General Correspondence sent
09 Jan 2019	IP Right Registration Published	Trade mark details »
09 Jan 2019	International Registration in Australia Protected correspondence sent
09 Jan 2019	Status change to Registered/Protected
06 Dec 2018	International Registration - Change Received
25 Oct 2018	IP Right Acceptance Published
22 Oct 2018	Clear Examination report approved
22 Oct 2018	User Created Notice correspondence sent
22 Oct 2018	Application Accepted correspondence sent
20 Oct 2018	Goods and Services Classes	More
	Event description Owner's Request Previous details Data as before the amendment: Amend No 12 Occurrence 1 05013 $ $ $ <BCLASS>0105 $ New details
20 Oct 2018	Goods and Services description amendment	More
	Event description Owner's Request Previous details Data as before the amendment: Amend No 13 Occurrence 1 Probiotic formulations, namely, capsules, suppositories, and lyophilized powders for medical purposes, in particular, for producing beneficial metabolites, modulating inflammation, increasing beneficial microbes, and inhibiting pathogens in the human microbiome; probiotic and prebiotic formulations, namely, capsules, suppositories, and lyophilized powders for the developing infant gut microbiome, for supporting healthy vaginal microbiomes in pregnant women and supporting healthy breastfeeding, and for increasing strains of beneficial bacteria in infants; pharmaceutical preparations for microbiome dysbiosis resulting from the use of antibiotic medications and consumer health interventions for the restoration of balance to a perturbed human microbiome New details
18 Sep 2018	Exam Response
07 Sep 2018	Amendment to Application/Registration
26 Aug 2018	International Registration 12-Month Refusal Notice correspondence sent
16 Oct 2017	International Bureau Adverse Examination Sent
16 Oct 2017	Application Status
16 Oct 2017	User Created Notice correspondence sent
16 Oct 2017	Adverse Report correspondence sent
07 Sep 2017	IP Right Filed Published
29 Aug 2017	Application Status
28 Aug 2017	Application Status
28 Aug 2017	Application Status
24 Aug 2017	Status change to Filed
24 Aug 2017	Madrid Import Application - 2 classes

Dates

Renewal due: 06 Jul 2027
Registered from: 10 Sep 2021
Entered on Register: 10 Sep 2021
Registration advertised / published: 09 Jan 2019
Acceptance advertised / published: 25 Oct 2018
Acceptance: 22 Oct 2018
IR notification: 24 Aug 2017
Filing: 06 Jul 2017

Owner

Address for service

IR Contact

Transformations

Partial transformation to: 2209940

Indexing constituents

Word